Shopping Cart
- Remove All
Your shopping cart is currently empty
MK-0159
🥰Excellent
Catalog No. T61933Cas No. 2641484-61-7
MK-0159 is an orally available, highly potent CD38 inhibitor with myocardial injury protection for the study of cardiac ischemia and reperfusion injury.
MK-0159
🥰Excellent
Purity: 99.72%
Catalog No. T61933Cas No. 2641484-61-7
MK-0159 is an orally available, highly potent CD38 inhibitor with myocardial injury protection for the study of cardiac ischemia and reperfusion injury.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $76 | In Stock | |
| 5 mg | $123 | In Stock | |
| 10 mg | $179 | In Stock | |
| 25 mg | $298 | In Stock | |
| 50 mg | $443 | In Stock | |
| 100 mg | $655 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "MK-0159"
CD38 inhibitor 1
T149131700637-55-3
CD38 inhibitor 1 is a potent CD38 inhibitor that is effective against human CD38 (IC50 value is 7.3 nM) and mouse CD38 (IC50 value is 1.9 nM).
- $51
Size
QTY
RBN013209
T600992597933-17-8
RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
- $56
Size
QTY
Mezagitamab
TAK-079, TAK079
T770842227490-52-8
Mezagitamab (TAK-079) is a fully humanized IgG1λ monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells), which depletes CD38-expressing tumor cells through antibody- and complement-dependent cytotoxicity Mezagitamab may be used in the study of recurrent/refractory multiple myeloma (RRMM), which is the most common form of cancer. multiple myeloma (RRMM) and primary thrombocytopenic purpura (ITP).
- $197
Size
QTY
Isatuximab
SAR-650984, Isatuximab-irfc, Isatuximab（anti-CD38）, hu38SB19
T389511461640-62-9
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38 in malignant cells of the hematological system, a highly expressed protein in multiple myeloma. It exhibits antitumor activity, antibody-dependent cytotoxicity, complement-dependent cytotoxicity, and antibody-dependent cytophagocytosis, directly inducing apoptosis without crosslinking. Isatuximab inhibits CD38 extracellular enzyme activity, affecting various cellular functions.
- $289
Size
QTY
Luteolinidin chloride
Cited
TN18951154-78-5
Luteolinidin chloride is a natural product. It is a potent CD38 inhibitor which can protect the heart against I/R injury with preservation of eNOS function and prevention of endothelial dysfunction in vivo.
- $72
Size
QTY
CitedFelzartamab
TJ-202, MOR-202, MOR-03087
T770062197112-39-1
Felzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.
- $247
Size
QTY
Erzotabart
T824402430792-01-9
Erzotabart, an IgG1-kappa monoclonal antibody targeting CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) in Homo sapiens, exhibits antineoplastic activity [1].
- Inquiry Price
Size
QTY
CD38 inhibitor 3
T797322857868-82-5
CD38 Inhibitor 3 (compound 1), with an IC50 of 11 nM, is a potent agent that enhances mitochondrial biogenesis, diminishes lactate levels, and augments both NAD+ content and Nrf2 expression. In a Pus1 -/- mouse model of mitochondrial myopathy, it also elevates muscle function and bolstering exercise capacity [1].
- $1,520
Size
QTY
Select Batch
Purity:99.72%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | MK-0159 is an orally available, highly potent CD38 inhibitor with myocardial injury protection for the study of cardiac ischemia and reperfusion injury. |
| Targets&IC50 | CD38 (mouse):3 nM, CD38 (rat):70 nM, CD38 (human):22±5 nM |
| In vitro | MK-0159 (0-50 μM, 24 hours) increased the levels of NAD+ both intracellularly and extracellularly in A549 cells and HMVEC cells[1]. |
| In vivo | In mice with cardiac ischemia/reperfusion injury, MK-0159 (30 mg/kg; oral) is capable of reducing infarct size[1]. |
| Molecular Weight | 400.495 |
| Formula | C20H24N4O3S |
| Cas No. | 2641484-61-7 |
| Smiles | COCCO[C@H]1CC[C@@H](CC1)NC(=O)c1cc(nc2[nH]ccc12)-c1cncs1 |
Storage & Solubility Information
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (199.75 mM), Sonification is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy MK-0159 | purchase MK-0159 | MK-0159 cost | order MK-0159 | MK-0159 chemical structure | MK-0159 in vivo | MK-0159 in vitro | MK-0159 formula | MK-0159 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.